Search Result
Results for "
AP-1
" in MedChemExpress (MCE) Product Catalog:
1
Biochemical Assay Reagents
1
Isotope-Labeled Compounds
Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-133987
-
|
NF-κB
|
Inflammation/Immunology
|
AP-1/NF-κB activation inhibitor 1 is a potent AP-1 and NF-κB mediated transcriptional activation inhibitor (IC50=1 μM), without blocking basal transcription driven by the β-actin promoter. AP-1/NF-κB activation inhibitor 1 has a similar inhibitory effect on the production of IL-2 and IL-8 levels in stimulated cells [1].
|
-
-
- HY-RS00776
-
|
Small Interfering RNA (siRNA)
|
Others
|
AP1B1 Human Pre-designed siRNA Set A contains three designed siRNAs for AP1B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
AP1B1 Human Pre-designed siRNA Set A
AP1B1 Human Pre-designed siRNA Set A
-
- HY-RS00777
-
|
Small Interfering RNA (siRNA)
|
Others
|
AP1G1 Human Pre-designed siRNA Set A contains three designed siRNAs for AP1G1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
AP1G1 Human Pre-designed siRNA Set A
AP1G1 Human Pre-designed siRNA Set A
-
- HY-RS00778
-
|
Small Interfering RNA (siRNA)
|
Others
|
AP1G2 Human Pre-designed siRNA Set A contains three designed siRNAs for AP1G2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
AP1G2 Human Pre-designed siRNA Set A
AP1G2 Human Pre-designed siRNA Set A
-
- HY-RS00779
-
|
Small Interfering RNA (siRNA)
|
Others
|
AP1M1 Human Pre-designed siRNA Set A contains three designed siRNAs for AP1M1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
AP1M1 Human Pre-designed siRNA Set A
AP1M1 Human Pre-designed siRNA Set A
-
- HY-RS00780
-
|
Small Interfering RNA (siRNA)
|
Others
|
AP1M2 Human Pre-designed siRNA Set A contains three designed siRNAs for AP1M2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
AP1M2 Human Pre-designed siRNA Set A
AP1M2 Human Pre-designed siRNA Set A
-
- HY-RS00781
-
|
Small Interfering RNA (siRNA)
|
Others
|
AP1S1 Human Pre-designed siRNA Set A contains three designed siRNAs for AP1S1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
AP1S1 Human Pre-designed siRNA Set A
AP1S1 Human Pre-designed siRNA Set A
-
- HY-RS00782
-
|
Small Interfering RNA (siRNA)
|
Others
|
AP1S2 Human Pre-designed siRNA Set A contains three designed siRNAs for AP1S2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
AP1S2 Human Pre-designed siRNA Set A
AP1S2 Human Pre-designed siRNA Set A
-
- HY-RS00783
-
|
Small Interfering RNA (siRNA)
|
Others
|
AP1S3 Human Pre-designed siRNA Set A contains three designed siRNAs for AP1S3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
AP1S3 Human Pre-designed siRNA Set A
AP1S3 Human Pre-designed siRNA Set A
-
- HY-10072
-
|
NF-κB
AP-1
|
Inflammation/Immunology
|
SPC 839 (compound 10) is an orally active inhibitor of AP-1 and NF-kB mediated transcriptional activation with IC50 of 0.008 μM [1].
|
-
-
- HY-15870
-
|
AP-1
|
Inflammation/Immunology
Cancer
|
SR 11302 is an activator protein-1 (AP-1) transcription factor inhibitor. SR 11302 is a retinoid that specifically inhibits AP-1 activity without activating the transcription of retinoic acid response element (RARE) [1].
|
-
-
- HY-119418
-
|
Estrogen Receptor/ERR
|
Cancer
|
Desketoraloxifene is an estrogen receptors alpha (ERα) activator at an AP-1 site. Desketoraloxifene can be used for the research of osteoporosis and breast cancer [1].
|
-
-
- HY-N2907
-
|
Ras
Endogenous Metabolite
|
Cancer
|
Atranorin is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1, Wnt, and STAT signaling and suppressing RhoGTPase activity [1] .
|
-
-
- HY-W008628S
-
-
-
- HY-15131
-
|
Interleukin Related
|
Inflammation/Immunology
|
PNRI-299 is a selective AP-1 transcription inhibitor with an IC50 of 20 uM. PNRI-299 is a selective APE/Ref-1 inhibitor. PNRI-299 has no effect on NF-κB transcription or thioredoxin (up to 200 uM). PNRI-299 significantly reduces airway eosinophil infiltration, mucus hypersecretion, edema, and IL-4 levels in a mouse asthma model [1] .
|
-
-
- HY-129239
-
ASLAN003
|
Dihydroorotate Dehydrogenase
DNA/RNA Synthesis
Apoptosis
|
Cancer
|
Farudodstat (ASLAN003) is an orally active and potent Dihydroorotate Dehydrogenase (DHODH) inhibitor with an IC50 of 35 nM for human DHODH enzyme. Farudodstat inhibits protein synthesis via activation of AP-1 transcription factors. Farudodstat induces apoptosis and substantially prolongs survival in acute myeloid leukemia (AML) xenograft mice [1] .
|
-
-
- HY-N10926
-
|
AP-1
|
Cancer
|
(+)-Glaucarubinone is a potent AP-1 (activator protein-1) inhibitor with an EC50 value of 0.13 µM. (+)-Glaucarubinone shows noncytotoxic [1].
|
-
-
- HY-121607
-
|
AP-1
Apoptosis
|
Cancer
|
INI-43 is an inhibitor of Kpnβ1, interfering with the nuclear localization of Kpnβ1 and known Kpnβ1 cargo proteins, NFAT, NFκB, AP-1, and NFY. INI-43 can inhibit the proliferation of cancer cells, cause G2-M cell cycle arrest in cancer cells, and induce the intrinsic apoptosis pathway [1] .
|
-
-
- HY-N4182
-
|
Akt
p38 MAPK
Autophagy
|
Inflammation/Immunology
|
Licochalcone E, a flavonoid compound isolated from Glycyrrhiza uralensis, inhibits NF-κB and AP-1 transcriptional activity through the inhibition of AKT and MAPK activation [1].
|
-
-
- HY-122808
-
|
mGluR
|
Metabolic Disease
|
(-)-Camphoric acid is the less active enantiomer of Camphoric acid. Camphoric acid stimulates osteoblast differentiation and induces glutamate receptor expression. Camphoric acid also significantly induced the activation of NF-κB and AP-1 [1].
|
-
-
- HY-P1185
-
|
Vasopressin Receptor
Apoptosis
|
Cancer
|
Antagonist G is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy [1] .
|
-
-
- HY-P1185A
-
|
Vasopressin Receptor
Apoptosis
|
Cancer
|
Antagonist G TFA is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy [1] .
|
-
-
- HY-N1513
-
|
AP-1
NF-κB
|
Cancer
|
Ganoderic acid H is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderic acid H suppresses growth and invasive behavior of breast cancer cells through the inhibition of transcription factors AP-1 and NF-kappaB signaling [1].
|
-
-
- HY-N10913
-
-
-
- HY-N0510
-
Aristolochic acid I; TR 1736
|
NF-κB
|
Cancer
|
Aristolochic acid A (Aristolochic acid I; TR 1736) is the main component of plant extract Aristolochic acids, which are found in various herbal plants of genus Aristolochia and Asarum. Aristolochic acid A significantly reduces both activator protein 1 (AP-1) and NF-κB activities. Aristolochic acid A reduces BLCAP gene expression in human cell lines [1].
|
-
-
- HY-155395
-
|
Others
|
Infection
|
DDAN-MT is an enzymatic activated near-infrared fluorescent probe. DDAN-MT can be used for rapid, highly selective, and real-time monitoring of endogenous MtMET-AP1 activity in M. tuberculosis [1].
|
-
-
- HY-100233
-
|
JNK
|
Inflammation/Immunology
Cancer
|
IQ-1S free acid is a prospective inhibitor of NF-κB/activating protein 1 (AP-1) activity with an IC50 of 2.3±0.41 μM. IQ-1S free acid has binding affinity (Kd values) in the nanomolar range for all three JNKs with Kds of 100 nM, 240 nM, and 360 nM for JNK3, JNK1, and JNK2, respectively.
|
-
-
- HY-151876
-
|
Glucocorticoid Receptor
NF-κB
AP-1
|
Inflammation/Immunology
|
Glucocorticoid receptor modulator 1 is a highly potent and orally active non-steroidal selective glucocorticoid receptor modulator with an IC50 value of 9 nM and 130 nM for NF-κB and AP-1, respectively. Glucocorticoid receptor modulator 1 can effectively reduce the expression of inflammatory factors IL-6, IL-1β, TNF-α, also can relieve dermatitis in mice [1].
|
-
-
- HY-RS02378
-
|
Small Interfering RNA (siRNA)
|
Others
|
CDK2AP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CDK2AP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
CDK2AP1 Human Pre-designed siRNA Set A
CDK2AP1 Human Pre-designed siRNA Set A
-
- HY-RS10510
-
|
Small Interfering RNA (siRNA)
|
Others
|
PIK3AP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3AP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PIK3AP1 Human Pre-designed siRNA Set A
PIK3AP1 Human Pre-designed siRNA Set A
-
- HY-RS01214
-
|
Small Interfering RNA (siRNA)
|
Others
|
ATP6AP1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATP6AP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
ATP6AP1 Human Pre-designed siRNA Set A
ATP6AP1 Human Pre-designed siRNA Set A
-
- HY-RS15947
-
|
Small Interfering RNA (siRNA)
|
|
YY1AP1 Human Pre-designed siRNA Set A contains three designed siRNAs for YY1AP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
YY1AP1 Human Pre-designed siRNA Set A
YY1AP1 Human Pre-designed siRNA Set A
-
- HY-RS11606
-
|
Small Interfering RNA (siRNA)
|
Others
|
RAD51AP1 Human Pre-designed siRNA Set A contains three designed siRNAs for RAD51AP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
RAD51AP1 Human Pre-designed siRNA Set A
RAD51AP1 Human Pre-designed siRNA Set A
-
- HY-110177
-
|
NF-κB
|
Inflammation/Immunology
|
SP-100030 is a potent NF-κB and activator protein-1 (AP-1) double inhibitor (IC50s=50 and 50 nM, respectively). SP-100030 inhibits IL-2, IL-8, and TNF-alpha production in Jurkat and other T cell lines. SP-100030 decreases murine collagen-induced arthritis (CIA) [1] .
|
-
-
- HY-W010983
-
SC-236
1 Publications Verification
|
COX
PPAR
Apoptosis
|
Cardiovascular Disease
Inflammation/Immunology
Cancer
|
SC-236 is an orally active COX-2 specific inhibitor (IC50 = 10 nM) and a PPARγ agonist. SC-236 suppresses activator protein-1 (AP-1) through c-Jun NH2-terminal kinase. SC-236 exerts anti-inflammatory effects by suppressing phosphorylation of ERK in a murine model [1] .
|
-
-
- HY-12270
-
T-5224
Maximum Cited Publications
48 Publications Verification
|
AP-1
MMP
|
Others
|
T-5224 is a transcription factor c-Fos/activator protein (AP)-1 inhibitor with anti-inflammatory effects, which specifically inhibits the DNA binding activity of c-Fos/c-Jun without affecting other transcription factors. T-5224 inhibits the IL-1β-induced up-regulation of Mmp-3, Mmp-13 and Adamts-5 transcription [1] .
|
-
-
- HY-19357
-
-
-
- HY-151883
-
|
Apoptosis
MDM-2/p53
|
Cancer
|
APE1-IN-2 (compound AP1) is a Pt(IV) proagent, targeting a critical BER protein, apurinic/apyrimidinic endonuclease 1 (APE1). APE1-IN-2 shows anticancer activity. APE1-IN-2 induces intracellular accumulation of platinum and activates DNA damage response and apoptosis signals [1].
|
-
-
- HY-13755A
-
L-SulforAPhane
|
Keap1-Nrf2
Bcl-2 Family
Caspase
Reactive Oxygen Species
NF-κB
|
Inflammation/Immunology
Cancer
|
(R)-Sulforaphane (L-Sulforaphane) is a orally active, potent inducer of the Keap1/Nrf2/ARE pathway, exhibiting antioxidant and anticancer activities. (R)-Sulforaphane primarily functions by upregulating phase II detoxifying enzymes in cells, aiding in the removal of carcinogens and combating oxidative stress. (R)-Sulforaphane is capable of modulating gene expression, influencing various signaling pathways, including Nrf2, NF-κB, and AP-1. (R)-Sulforaphane can be used in studies of tumor biology, antioxidant defense mechanisms, as well as inflammation and immune responses [1] .
|
-
-
- HY-141645
-
WS070117
|
AMPK
TGF-β Receptor
NF-κB
JNK
AP-1
|
Cardiovascular Disease
Metabolic Disease
Inflammation/Immunology
|
IMM-H007 (WS070117) is an orally active and potent AMPK (AMP-activated protein kinase) activator and TGFβ1 (transforming growth factor β1) antagonist. IMM-H007 has protective effects in cardiovascular diseases via activation of AMPK. IMM-H007 negatively regulates endothelium inflammation through inactivating NF-κB and JNK/AP1 signaling. IMM-H007 inhibits ABCA1 degradation. IMM-H007 resolves hepatic steatosis in HFD-fed hamsters by the regulation of lipid metabolism. IMM-H007 can be used for the research of nonalcoholic fatty liver disease (NAFLD) and inflammatory atherosclerosis [1] .
|
-
-
- HY-N3261
-
|
AP-1
ERK
STAT
|
Inflammation/Immunology
Cancer
|
Methyllinderone is an inhibitor of AP-1/STAT/ERK. Methyllinderone has anti-inflammatory effect. Methyllinderone reduce the invasion and migration rate of TPA-stimulated MCF-7 cells. Methyllinderone can be used in study breast cancer metastasis [1].
|
-
-
- HY-N6257
-
|
ERK
PGE synthase
COX
NF-κB
|
Inflammation/Immunology
Cancer
|
Cafestol, one of the major components of coffee, is a coffee-specific diterpene from. Cafestol is a ERK inhibitor for AP-1-targeted activity against PGE2 production and the mRNA expression of cyclooxygenase (COX)-2 in LPS-activated RAW264.7 cells. Cafestol has strong inhibitory activity on PGE2 production by suppressing the NF-kB activation pathway. Cafestol contributes to its beneficial effects through various biological activities such as chemopreventive, antitumorigenic, hepatoprotective, antioxidative and antiinflammatory effects [1].
|
-
-
- HY-N6868
-
dmLSB
|
Sodium Channel
|
Cardiovascular Disease
|
Dimethyl lithospermate B (dmLSB) is a selective Na + channel agonist. Dimethyl lithospermate B slows inactivation of sodium current (INa), leading to increased inward current during the early phases of the action potential (AP) .
|
-
-
- HY-107436
-
LE135
1 Publications Verification
|
RAR/RXR
TRP Channel
|
Neurological Disease
Cancer
|
LE135 is a potent RAR antagonist that binds selectively to RARα (Ki of 1.4 μM) and RARβ (Ki of 220 nM), and has a higher affinity to RARβ. LE135 is highly selective over RARγ, RXRα, RXRβ and RXRγ. LE135 is also a potent TRPV1 and TRPA1 receptors activator with EC50s of 2.5 μM and 20 μM, respectively [1] .
|
-
-
- HY-N4226
-
|
AP-1
|
Inflammation/Immunology
Cancer
|
1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid is from Cordyceps bassiana, which is one of Cordyceps species with anti-oxidative, anti-cancer, anti-inflammatory, anti-diabetic, anti-obesity, anti-angiogenic, and anti-nociceptive activities. 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid targets to block AP-1-mediated luciferase activity, implying it has an anti-inflammatory function [1].
|
-
-
- HY-129113
-
|
COX
|
Inflammation/Immunology
|
α-Chaconine inhibits the expressions of COX-2, IL-1β, IL-6, and TNF-α at the transcriptional level. α-Chaconine inhibits the LPS-induced expressions of iNOS and COX-2 at the protein and mRNA levels and their promoter activities in RAW 264.7 macrophages. Anti-inflammatory effects [1].
|
-
-
- HY-N1190
-
(±)-Syringaresinol
|
|
|
DL-Syringaresinol ((±)-Syringaresinol), a lignin, inhibits UVA-induced upregulation of MMP-1 by suppressing MAPK/AP-1 signaling in human HaCaT keratinocytes and dermal fibroblasts (HDFs). DL-Syringaresinol has antiphotoaging properties against UVA-induced skin aging. DL-Syringaresinol exhibits weak antimycobacterial activity against Mycobacterium tuberculosis H37Rv [1] .
|
-
-
- HY-P2036A
-
|
Toll-like Receptor (TLR)
MMP
HSV
Antibiotic
|
Infection
|
FSL-1 TFA, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection [1]. FSL-1 TFA induces MMP-9 production through TLR2 and NF-κB/AP-1 signaling pathways in monocytic THP-1 cells .
|
-
-
- HY-N10156
-
-
-
- HY-N1326
-
Santamarin; Balchanin
|
Keap1-Nrf2
|
Inflammation/Immunology
|
Santamarine (Santamarin), a sesquiterpene lactone, increases HO-1 expression through Nrf2 translocation and suppresses NO, PGE2, TNF-α, and IL-1β production through inhibition of NF-κB translocation in LPS-induced macrophages. Santamarine shows anti-photoaging properties via inhibition of MAPK/AP-1 and stimulation of TGF-β/Smad signaling in UVA-irradiated human dermal fibroblasts (HDFs). Antioxidant activities [1] .
|
-
- HY-W016412
-
-
-
-
HY-L090
-
|
1288 compounds
|
Transcription is the essential first step in the conversion of the genetic information in the DNA into protein and the major point at which gene expression is controlled. Transcription of protein-coding genes is accomplished by the multi-subunit enzyme RNA polymerase II and an ensemble of ancillary proteins, called transcription factors (TFs). Transcription factors play an important role in the long-term regulation of cell growth, differentiation and responses to environmental cues. Deregulated transcription factors contribute to the pathogenesis of a plethora of human diseases, ranging from diabetes, inflammatory disorders and cardiovascular disease to many cancers, and thus these proteins hold great therapeutic potential.
MCE offers a unique collection of 1288 compounds with validated transcription factor targets modulating properties. MCE transcription factor-targeted compound library is an effective tool for researching transcription factors as drug targets as well as modulation of TFs for different therapeutic applications.
|
Cat. No. |
Product Name |
Type |
-
- HY-W016412
-
CoQ0
|
Biochemical Assay Reagents
|
Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound can be derived from Antrodia cinnamomea. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance. Coenzyme Q0 has anti-angiogenic activity through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling [1] .
|
Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-P1185
-
|
Vasopressin Receptor
Apoptosis
|
Cancer
|
Antagonist G is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy [1] .
|
-
- HY-P2036A
-
|
Toll-like Receptor (TLR)
MMP
HSV
Antibiotic
|
Infection
|
FSL-1 TFA, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection [1]. FSL-1 TFA induces MMP-9 production through TLR2 and NF-κB/AP-1 signaling pathways in monocytic THP-1 cells .
|
-
- HY-P1185A
-
|
Vasopressin Receptor
Apoptosis
|
Cancer
|
Antagonist G TFA is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy [1] .
|
Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
-
- HY-N2907
-
-
-
- HY-N10926
-
-
-
- HY-N4182
-
-
-
- HY-122808
-
-
-
- HY-N1513
-
-
-
- HY-N10913
-
-
-
- HY-N0510
-
-
-
- HY-13755A
-
-
-
- HY-N3261
-
-
-
- HY-N6257
-
-
-
- HY-N6868
-
-
-
- HY-N4226
-
|
other families
Microorganisms
Classification of Application Fields
Ketones, Aldehydes, Acids
Source classification
Plants
Disease Research Fields
Cancer
|
AP-1
|
1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid is from Cordyceps bassiana, which is one of Cordyceps species with anti-oxidative, anti-cancer, anti-inflammatory, anti-diabetic, anti-obesity, anti-angiogenic, and anti-nociceptive activities. 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid targets to block AP-1-mediated luciferase activity, implying it has an anti-inflammatory function [1].
|
-
-
- HY-129113
-
-
-
- HY-N10156
-
-
-
- HY-N1326
-
-
Cat. No. |
Compare |
Product Name |
Species |
Source |
Compare Products
|
Products |
|
Cat. No. |
|
Species |
|
Source |
|
Tag |
|
Accession |
|
Gene ID |
|
Molecular Weight |
|
Purity |
|
Endotoxin Level |
|
Biological Activity |
|
Appearance |
|
Formulation |
|
Storage & Stability |
|
Shipping |
|
Free Sample |
Yes
No
|
Size |
* This product has been "discontinued".
Optimized version of product available:
|
Cat. No. |
Product Name |
Chemical Structure |
-
- HY-W008628S
-
|
Bisphenol AP-d5 is the deuterium labeled Bisphenol AP[1].
|
-
Cat. No. |
Product Name |
Application |
Reactivity |
-
- HY-P80802
-
Transcription factor AP-1; Activator protein 1; AP1; Proto-oncogene c-Jun; V-jun avian sarcoma virus 17 oncogene homolog; p39
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-c-Jun (Ser73) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser73). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P83342
-
Activator protein 1; AP 1; Jun D; jun D proto oncogene; Jund; JunD FL isoform; Transcription factor jun D
|
WB, IP
|
Human, Mouse, Rat |
-
- HY-P82548
-
Activator protein 1; AP 1; Jun D; jun D proto oncogene; Jund; JunD FL isoform; Transcription factor jun D
|
WB, IHC-P, ICC/IF
|
Human, Mouse, Rat |
-
- HY-P82861
-
JUN; Transcription factor AP-1; Activator protein 1; AP1; Proto-oncogene c-Jun; V-jun avian sarcoma virus 17 oncogene homolog; p39; JUND; Transcription factor jun-D
|
WB, IP
|
Human, Mouse, Rat |
-
- HY-P80801
-
Transcription factor AP-1; Activator protein 1; AP1; Proto-oncogene c-Jun; V-jun avian sarcoma virus 17 oncogene homolog; p39
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-c-Jun (Ser63) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser63). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P80800
-
Transcription factor AP-1; Activator protein 1; AP1; Proto-oncogene c-Jun; V-jun avian sarcoma virus 17 oncogene homolog; p39
|
WB, IHC-P
|
Human, Mouse, Rat |
Phospho-c-Jun (Ser243) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser243). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
|
-
- HY-P83248
-
ADTG; AP1G1; CLAPG1
|
WB, IHC-P
|
Human, Mouse, Rat |
-
- HY-P80649
-
EIF1A; EIF4C; eIF-1A; eIF-4C; EIF1AP1
|
WB, IHC-F, IHC-P, ICC/IF, IP
|
Human, Mouse, Rat |
eIF1A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 16 kDa, targeting to eIF1A. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: